Post by P95

📢 We are excited to share important news! Today, P95 and Julius Clinical have merged to form a global, mid-sized, full-service contract research organization (CRO) - uniting complementary strengths in clinical development and real-world evidence. By combining P95’s expertise in infectious diseases, vaccines, and real-world evidence with Julius Clinical’s leadership in neuroscience and cardio-renal-metabolic research, we are expanding our global reach and reinforcing our shared commitment to advancing health through high-quality, science-led research. Led by CEO Bassem Saleh, with founder Thomas Verstraeten continuing as Board Member and Senior Advisor, this new organization is uniquely positioned to advance high-quality, science-driven research that improves health worldwide. A huge milestone and an exciting new chapter for both teams! 👉 Read the full press release to learn more: https://lnkd.in/dWrQK-xv #P95 #JuliusClinical #CRO #ClinicalResearch #RealWorldEvidence #InfectiousDiseases #Vaccines #Neuroscience #CardioRenalMetabolic #GlobalHealth #AdvancingHealth Ampersand Capital Partners